These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 38605214)
1. LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Cao N; Zhang F; Yin J; Zhang J; Bian X; Zheng G; Li N; Lin Y; Luo L Oncogene; 2024 May; 43(22):1714-1725. PubMed ID: 38605214 [TBL] [Abstract][Full Text] [Related]
2. A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11/GPX4 axis. Wang W; Zhao X; Zhou J; Li H Funct Integr Genomics; 2024 Jul; 24(4):126. PubMed ID: 39012393 [TBL] [Abstract][Full Text] [Related]
3. CRISPR screening identifies PRMT1 as a key pro-ferroptotic gene via a two-layer regulatory mechanism. Zhang X; Duan Y; Li S; Zhang Z; Peng L; Ma X; Wang T; Xiang S; Chen G; Zhou D; Lu D; Qian M; Wang Z Cell Rep; 2024 Sep; 43(9):114662. PubMed ID: 39178116 [TBL] [Abstract][Full Text] [Related]
4. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662 [TBL] [Abstract][Full Text] [Related]
5. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis. Li Q; Li K; Guo Q; Yang T Environ Toxicol; 2023 May; 38(5):981-989. PubMed ID: 36840697 [TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer. Huang F; Huang Z; Wei Q; Liu G; Pu J Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058 [TBL] [Abstract][Full Text] [Related]
7. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374 [TBL] [Abstract][Full Text] [Related]
8. UBR5 mediates colorectal cancer chemoresistance by attenuating ferroptosis via Lys 11 ubiquitin-dependent stabilization of Smad3-SLC7A11 signaling. Song M; Huang S; Wu X; Zhao Z; Liu X; Wu C; Wang M; Gao J; Ke Z; Ma X; He W Redox Biol; 2024 Oct; 76():103349. PubMed ID: 39260061 [TBL] [Abstract][Full Text] [Related]
9. Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation. Zhang C; Liu H; Li X; Xiao N; Chen H; Feng H; Li Y; Yang Y; Zhang R; Zhao X; Du Y; Bai L; Ma R; Wan J Redox Biol; 2024 Sep; 75():103299. PubMed ID: 39127016 [TBL] [Abstract][Full Text] [Related]
10. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Xu X; Zhang X; Wei C; Zheng D; Lu X; Yang Y; Luo A; Zhang K; Duan X; Wang Y Eur J Pharm Sci; 2020 Sep; 152():105450. PubMed ID: 32621966 [TBL] [Abstract][Full Text] [Related]
11. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia. Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835 [TBL] [Abstract][Full Text] [Related]
12. miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11. Elrebehy MA; Abdelghany TM; Elshafey MM; Gomaa MH; Doghish AS Pathol Res Pract; 2023 Jul; 247():154557. PubMed ID: 37229918 [TBL] [Abstract][Full Text] [Related]
13. PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis. Liu H; Chen X; Wang P; Chen M; Deng C; Qian X; Bai J; Li Z; Yu X Cell Death Dis; 2024 Feb; 15(2):170. PubMed ID: 38402202 [TBL] [Abstract][Full Text] [Related]
14. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495 [TBL] [Abstract][Full Text] [Related]
15. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771 [No Abstract] [Full Text] [Related]
16. C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11. Wang S; Yu H; Guo P; Feng L; Li Z Funct Integr Genomics; 2024 Sep; 24(5):163. PubMed ID: 39292359 [TBL] [Abstract][Full Text] [Related]
17. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression. Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859 [No Abstract] [Full Text] [Related]
18. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma. Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976 [TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer. Liu X; Ma Z; Jing X; Wang G; Zhao L; Zhao X; Zhang Y Cancer Lett; 2024 Nov; 604():217232. PubMed ID: 39276913 [TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer. Liu R; Wang Y; Bu J; Li Q; Chen F; Zhu M; Chi H; Yu G; Zhu T; Zhu X; Zhao G Int J Med Sci; 2024; 21(6):1103-1116. PubMed ID: 38774759 [No Abstract] [Full Text] [Related] [Next] [New Search]